Duramycin
Duramycin structure
|
Common Name | Duramycin | ||
|---|---|---|---|---|
| CAS Number | 1391-36-2 | Molecular Weight | 1999.25000 | |
| Density | 1.0238 (rough estimate) | Boiling Point | N/A | |
| Molecular Formula | C89H125N23O25S3 | Melting Point | 271-273ºC | |
| MSDS | Chinese USA | Flash Point | N/A | |
Use of DuramycinDuramycin (Moli1901;Lancovutide) is a cyclic peptide lantibiotic derived from Streptomyces cinnamoneuma. Duramycin stimulates chloride secretion in airway epithelium and has the potential for cystic fibrosis treatment. Duramycin interacts with phosphatidylethanolamine (PE) and has antibacterial, antiviral effects[1][2]. |
| Name | Duramycin |
|---|---|
| Synonym | More Synonyms |
| Description | Duramycin (Moli1901;Lancovutide) is a cyclic peptide lantibiotic derived from Streptomyces cinnamoneuma. Duramycin stimulates chloride secretion in airway epithelium and has the potential for cystic fibrosis treatment. Duramycin interacts with phosphatidylethanolamine (PE) and has antibacterial, antiviral effects[1][2]. |
|---|---|
| Related Catalog | |
| In Vitro | Duramycin does stimulate Cl- efflux from cystic fibrosis bronchial epithelial cells (CFBE) in a narrow concentration range (around 1 μM). However, 100 and 250 μM of Duramycin inhibits Cl- efflux from CFBE cells. The [Ca2+]i is increased by 3 μM Duramycin in 16HBE cells, but decreases after 1, and 3 μM of Duramycin in CFBE cells[1]. Duramycin affects protein-lipid interactions, impairs protein translocation, induces aggregation of lipid vesicles, and inhibits ATP-dependent Ca2+ uptake by the sarcoplasmic reticulum[1]. |
| In Vivo | Evaluation of [68Ga]NODAGA-Duramycin as a positron emission tomography (PET) tracer of cell death for whole-body detection of chemotherapy-induced organ toxicity. Organ uptake is analyzed in untreated and doxorubicin, busulfan, and cisplatin-treated mice 2 h after intravenous injection of [68Ga]NODAGA-Duramycin. [68Ga]NODAGA-Duramycin PET/CT is successfully applied to non-invasively detect chemotherapy-induced organ toxicity with high sensitivity in mice[3]. |
| References |
| Density | 1.0238 (rough estimate) |
|---|---|
| Melting Point | 271-273ºC |
| Molecular Formula | C89H125N23O25S3 |
| Molecular Weight | 1999.25000 |
| Exact Mass | 1997.82000 |
| PSA | 835.99000 |
| Index of Refraction | 1.6680 (estimate) |
| Storage condition | 2-8°C |
| Water Solubility | 0.1 M HCl: soluble10mg/mL |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
| Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
|---|---|
| RIDADR | NONH for all modes of transport |
| RTECS | BV7100000 |
|
Stimulation of sodium transport by duramycin in cultured human colonic epithelia.
J. Pharmacol. Exp. Ther. 259 , 1050, (1991) Effects of two peptide antibiotics, duramycin and Ro 09-0198, on ion transport in cultured human colonic epithelia were investigated. Both peptides acted on the apical face of epithelial monolayers, c... |
|
|
Upregulated function of mitochondria-associated ER membranes in Alzheimer disease.
EMBO J. 31 , 4106-23, (2012) Alzheimer disease (AD) is associated with aberrant processing of the amyloid precursor protein (APP) by γ-secretase, via an unknown mechanism. We recently showed that presenilin-1 and -2, the catalyti... |
|
|
Phosphatidylethanolamine is externalized at the surface of microparticles.
Biochim. Biophys. Acta 1821(12) , 1501-7, (2012) Microparticles (MPs) are membrane-bound vesicles shed normally or as a result of various (pathological) stimuli. MPs contain a wealth of bio-active macromolecules. Aminophospholipid phosphatidylserine... |
| UNII-BPR0F3X56H |
| Lancovutide [INN] |
| Ancovenin,2-L-lysine-6-(3-aminoalanine)-10-L-phenylalanine-12-L-phenylalanine-13-L-valine-15-(erythro-3-hydroxy-L-aspartic acid)-,cyclic 6-19)-imine |
| Leucopeptin |
| LANCOVUTIDE |